Fermenta Biotech Limited (BOM:506414)
498.35
-4.45 (-0.89%)
At close: Sep 4, 2026
Fermenta Biotech Market Cap
Fermenta Biotech has a market cap or net worth of 14.29 billion as of September 4, 2026. Its market cap has increased by 48.12% in one year.
Market Cap
14.29B
Enterprise Value
15.04B
Revenue
5.11B
Ranking
n/a
PE Ratio
24.44
Stock Price
498.35
ChartMarket Cap Chart
Since July 31, 1998, Fermenta Biotech's market cap has increased from 335.80M to 14.29B, an increase of 4,154.94%. That is a compound annual growth rate of 14.27%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 14.29B | 39.50% |
| Dec 31, 2025 | 10.24B | -4.38% |
| Dec 31, 2024 | 10.71B | 129.56% |
| Dec 29, 2023 | 4.67B | -6.88% |
| Dec 30, 2022 | 5.01B | -40.13% |
| Dec 31, 2021 | 8.37B | -8.61% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Fredun Pharmaceuticals | 24.38B |
| Shukra Pharmaceuticals | 22.84B |
| Venus Remedies | 22.58B |
| Syncom Formulations (India) | 19.33B |
| TTK Healthcare | 15.55B |
| Amrutanjan Health Care | 14.64B |
| Lincoln Pharmaceuticals | 12.39B |
| Kopran | 11.24B |